The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
SOPHIA analysis by chemotherapy (Ctx) choice: A phase III (P3) study of margetuximab (M) + Ctx versus trastuzumab (T) + Ctx in patients (pts) with pretreated HER2+ metastatic (met) breast cancer (MBC).
 
Santiago Escrivá
Consulting or Advisory Role - Pierre Fabre; Roche
Speakers' Bureau - Eisai; Pierre Fabre; Roche
Research Funding - Roche (Inst); Synthon (Inst)
Travel, Accommodations, Expenses - Daiichi Sankyo; Pierre Fabre; Roche
 
Seock-Ah Im
Consulting or Advisory Role - Amgen; AstraZeneca; Eisai; Hanmi; Lilly; medpacto; Novartis; Pfizer; Roche/Genentech
Research Funding - AstraZeneca; Pfizer; Roche/Genentech
Travel, Accommodations, Expenses - Novartis; Roche/Genentech
Other Relationship - Roche
 
Fatima Cardoso
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Celgene; Daiichi Sankyo; Eisai; GE Healthcare; Genentech; GlaxoSmithKline; Macrogenics; Medscape; Merck Sharp & Dohme; Merus; Mundipharma; Mylan; Novartis; Pfizer; Pierre Fabre; Prime Oncology; Roche; Samsung Bioepis; Sanofi; Seagen; Teva
Travel, Accommodations, Expenses - AstraZeneca; Pfizer; Roche
 
Javier Cortes
Stock and Other Ownership Interests - MedSIR
Honoraria - Celgene; Daiichi Sankyo; Eisai; Lilly; Merck Sharp & Dohme; Novartis; Pfizer; Roche; Samsung
Consulting or Advisory Role - AstraZeneca; Athenex; Bioasis; Biothera; Celgene; Cellestia Biotech; Clovis Oncology; Daiichi Sankyo; ERYTECH Pharma; GlaxoSmithKline; Leuko; Lilly; Merck Sharp & Dohme; Merus; Polyphor; Roche; Seagen; SERVIER
Research Funding - ARIAD (Inst); AstraZeneca (Inst); Baxalta (Inst); Bayer (Inst); Eisai (Inst); Guardant Health (Inst); Merck Sharp & Dohme (Inst); Pfizer (Inst); Piqur (Inst); Puma Biotechnology (Inst); Queen Mary university of London (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Daiichi Sankyo; Eisai; Novartis; Pfizer; Roche
 
Giuseppe Curigliano
Honoraria - Ellipses Pharma
Consulting or Advisory Role - Bristol-Myers Squibb; Foundation Medicine; Lilly; Novartis; Pfizer; Roche/Genentech; Samsung
Speakers' Bureau - Daiichi Sankyo; Foundation Medicine; Lilly; Novartis; Pfizer; Roche/Genentech; Samsung
Travel, Accommodations, Expenses - Pfizer; Roche/Genentech
 
William John Gradishar
Consulting or Advisory Role - Carrick Therapeutics; Lilly; MacroGenics; Pfizer; Puma Biotechnology; Roche/Genentech; Seagen
Research Funding - Macrogenics
 
Mark D. Pegram
Honoraria - AstraZeneca; Genentech/Roche; Macrogenics; Novartis; Pfizer; Samsung Bioepis; Seagen
Consulting or Advisory Role - Genentech/Roche; Macrogenics; Novartis; Pfizer; Samsung Bioepis; Seagen
 
Gail Lynn Shaw Wright
Stock and Other Ownership Interests - Macrogenics (I); Odonate Therapeutics; Puma Biotechnology; Roche
Research Funding - Abbvie; Astellas Pharma; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; E.R. Squibb Sons, LLC; G1 Therapeutics; Genentech; H3 Biomedicine; Incyte; Innocrin Pharma; Janssen; Lilly; Medivation; Novartis; Nucana; Pfizer; Seagen; Taiho Pharmaceutical; Tesaro
 
Christelle Levy
No Relationships to Disclose
 
Michelino De Laurentiis
Honoraria - Eisai; Lilly; M&S Decisions; Merck Sharp & Dohme; Novartis; Pfizer; Roche
Consulting or Advisory Role - Amgen; Eisai; Lilly; Merck Sharp & Dohme; Novartis; Pfizer; Roche
Speakers' Bureau - Amgen; Eisai; Lilly; Merck Sharp & Dohme; Novartis; Pfizer; Roche
Research Funding - Daiichi Sankyo; MacroGenics; Merck; Novartis; Roche
 
Jean-Marc Ferrero
No Relationships to Disclose
 
Shakeela Wazeen Bahadur
No Relationships to Disclose
 
Sung-Bae Kim
Honoraria - DAEHWA Pharmaceutical; Enzychem Lifesciences; ISU ABXIS
Consulting or Advisory Role - AstraZeneca; DAEHWA Pharmaceutical; Enzychem Lifesciences (Inst); ISU Abxis; Lilly (Inst)
Research Funding - Dongkook Pharma (Inst); Genzyme (Inst); Kyowha Kirin (Inst); Novartis (Inst)
 
Katarína Petráková
Consulting or Advisory Role - Bristol-Myers Squibb; Lilly; Pfizer; Roche
Speakers' Bureau - Bristol-Myers Squibb; Lilly; Pfizer; Roche
Research Funding - Macrogenics
 
David A. Riseberg
Consulting or Advisory Role - Pfizer
Speakers' Bureau - Novartis
Research Funding - Daiichi Sankyo (Inst); Macrogenics (Inst); Novartis (Inst); Roche (Inst); Seagen (Inst)
 
Denise A. Yardley
Consulting or Advisory Role - Biotheranostics (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Daiichi Sankyo/Lilly (Inst); Eisai (Inst); Genentech/Roche (Inst); NanoString Technologies (Inst); Novartis (Inst)
Speakers' Bureau - Genentech/Roche; Genentech/Roche; Novartis
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Clovis Oncology (Inst); Daiichi Sankyo (Inst); Eisai (Inst); Genentech/Roche (Inst); Immunomedics (Inst); InventisBio (Inst); Lilly (Inst); Macrogenics (Inst); MedImmune (Inst); Medivation (Inst); Merck (Inst); Novartis (Inst); Oncothyreon (Inst); Pfizer (Inst); Syndax (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - Genentech/Roche; Novartis
 
Sutton Edlich
Employment - Macrogenics
Stock and Other Ownership Interests - MacroGenics
 
Sam Hong
Employment - Macrogenics
Stock and Other Ownership Interests - Macrogenics
 
Edwin P. Rock
Employment - MacroGenics
Stock and Other Ownership Interests - MacroGenics
Travel, Accommodations, Expenses - MacroGenics
 
Hope S. Rugo
Consulting or Advisory Role - Celltrion; Ionis Pharmaceuticals
Research Funding - Daiichi Sankyo (Inst); Eisai (Inst); Genentech (Inst); Immunomedics (Inst); Lilly (Inst); Macrogenics (Inst); Merck (Inst); Novartis (Inst); OBI Pharma (Inst); Odonate Therapeutics (Inst); Pfizer (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Daiichi Sankyo; Macrogenics; Merck; Mylan; Novartis; OBI Pharma; Pfizer; Puma Biotechnology